PS
NVAX icon

PayPay Securities’s Novavax NVAX Stock Holding History

PayPay Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$933 Sell
99
-17
-15% -$152 0.02% 242
2026
Q1 		$1K Sell
116
-62
-35% -$562 0.03% 247
2025
Q4 		$1.2K Buy
178
+60
+51% +$452 0.04% 225
2025
Q3 		$1.02K Buy
118
+65
+123% +$506 0.04% 224
2025
Q2 		$334 Buy
53
+7
+15% +$46 0.02% 262
2025
Q1 		$298 Buy
46
+5
+12% +$41 0.02% 268
2024
Q4 		$330 Buy
41
+15
+58% +$145 0.01% 252
2024
Q3 		$328 Sell
26
-458
-95% -$5.91K 0.03% 164
2024
Q2 		$6.13K Sell
484
-876
-64% -$8.81K 0.51% 41
2024
Q1 		$6.5K Buy
1,360
+643
+90% +$2.98K 0.32% 61
2023
Q4 		$3.44K Sell
717
-683
-49% -$4.18K 0.17% 137
2023
Q3 		$10.1K Buy
1,400
+1,351
+2,757% +$10.8K 0.46% 53
2023
Q2 		$364 Buy
49
+17
+53% +$134 0.02% 178
2023
Q1 		$222 Buy
32
+7
+28% +$64 0.01% 180
2022
Q4 		$257 Buy
+25
New +$441 0.02% 172

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

PayPay Securities's NVAX Position: Q2 2026 in Review

PayPay Securities reduced its Novavax (NVAX) stake by 15% in Q2 2026, selling an estimated $152 and leaving 99 shares worth $933. The position accounts for 0.02% of the portfolio, ranked #242.

PayPay Securities first reported a position in NVAX in Q4 2022 and has held it in 15 quarters since. The position peaked at $10.1K in Q3 2023. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • PayPay Securities held 99 shares of Novavax worth $933 as of Q2 2026.
  • PayPay Securities sold 17 Novavax shares in Q2 2026, an estimated $152.
  • Novavax made up 0.02% of PayPay Securities's portfolio in Q2 2026, its #242 holding.
  • PayPay Securities first reported a position in Novavax in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's Novavax position peaked at $10.1K in Q3 2023.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.